Recommendations for the diagnosis and management of persons with suspected vaccine-induced immune thrombotic thrombocytopenia (VITT)
In recent months, rare cases of thrombosis at unusual sites associated with thrombocytopenia, occurring within a typical risk window (i.e., 4-28 days) after receiving SARS CoV2 vaccines, have been reported. Healthcare professionals should be prepared to detect these cases on time. The Expert Panel o...
Saved in:
Main Author: | Nancy Yomayusa (Author) |
---|---|
Format: | Book |
Published: |
Asociación Colombiana de Infectología,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Most cases of Thrombosis and Thrombocytopenia Syndrome (TTS) post ChAdOx-1 nCov-19 are Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)
by: Michael Makris, et al.
Published: (2022) -
COVID-19 vaccine-induced immune thrombotic thrombocytopenia
by: A. B. Sugraliyev, et al.
Published: (2022) -
Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses
by: S. V. Akinshina, et al.
Published: (2021) -
Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia
by: Young Shil Park
Published: (2021) -
A Case of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia
by: Abhinandan Chittal, et al.
Published: (2021)